This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Carlos A. Labarrere, MD; David R. Nelson, MS; W. Page Faulk, MD, FRCPath

JAMA. 1997;278(14):1169-1175.

Abstract
Context.
—The development of coronary artery disease in heart transplants is often associated with graft failure. Early detection of allografts prone to develop this disease is essential to institute new therapeutic approaches that could prolong allograft function.

Objective.
—To determine if early activation of arterial/arteriolar endothelium predicts the development of coronary artery disease, graft failure, or both in transplanted human hearts.

Design.
—Prospective cohort study.

Setting.
—Heart Transplant Center.

Participants.
—A total of 121 consecutive adult cardiac allograft recipients who received transplants between 1988 and 1995 and were followed up through 1996.

Main Outcome Measures.
—Development of coronary artery disease and graft failure.

Methods.
—Immunocytochemistry was performed on serial endomyocardial biopsy specimens to evaluate endothelial activation markers (intercellular adhesion molecule-1 and histocompatibility antigen HLA-DR) in arteries and arterioles. The presence and progression of coronary artery disease was evaluated by annual coronary angiograms with side-by-side comparisons.

Results.
—None of the 121 donor hearts showed arterial/arteriolar endothelial activation before transplantation. Arterial/arteriolar endothelial activation was present in 78 and absent in 43 of 121 allografts during the first 3 months after transplantation. The time of appearance and the proportion of biopsy specimens showing endothelial activation during these first 3 months were significantly associated with the risk of developing coronary artery disease, the progression of the disease, and the time required to develop the disease (P<.001). Significantly more patients with arterial/arteriolar endothelial activation died or received a second transplant (P<.001).

Conclusions.
—Activation of arterial/arteriolar endothelium in transplanted human hearts predicts development of coronary artery disease and increased risk of graft failure.

Author Affiliations
From the Center for Reproduction and Transplantation Immunology, Methodist Research Institute (Drs Labarrere and Faulk), and the Center for Health Services Research (Mr Nelson), Clarian Health (Methodist, Indiana University, and Riley Hospitals), Indianapolis, Ind.

Footnotes
Reprints: Carlos A. Labarrere, MD, Center for Reproduction and Transplantation Immunology, Methodist Research Institute, Clarian Health, 1701 N Senate Blvd, Indianapolis, IN 46202.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cardiac Allograft Vasculopathy: Recent Developments
Schmauss and Weis
Circulation 2008;117:2131-2141.
ABSTRACT | FULL TEXT  

Laminar flow attenuates interferon-induced inflammatory responses in endothelial cells
Tsai et al.
Cardiovasc Res 2007;74:497-505.
ABSTRACT | FULL TEXT  

T Cell Costimulation in the Development of Cardiac Allograft Vasculopathy: Potential Targets for Therapeutic Interventions
Isobe et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:1447-1456.
ABSTRACT | FULL TEXT  

Cytomegalovirus Infection in Heart Transplant Recipients Is Associated With Impaired Endothelial Function
Petrakopoulou et al.
Circulation 2004;110:II-207-II-212.
ABSTRACT | FULL TEXT  

Prolonged donor ischemic time does not adversely affect long-term survival in adult patients undergoing cardiac transplantation
Morgan et al.
J. Thorac. Cardiovasc. Surg. 2003;126:1624-1633.
ABSTRACT | FULL TEXT  

Cardiac Allograft Vasculopathy and Dysregulation of the NO Synthase Pathway
Weis and Cooke
Arterioscler. Thromb. Vasc. Bio. 2003;23:567-575.
ABSTRACT | FULL TEXT  

Alive and Kicking: Endothelium at the Geographic Nexus of Vascular Rejection
Mazer and Pinsky
Circ. Res. 2002;91:1085-1088.
FULL TEXT  

Circulating Autoantibodies to Oxidized LDL Correlate With Impaired Coronary Endothelial Function After Cardiac Transplantation
Fang et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:2044-2048.
ABSTRACT | FULL TEXT  

Allograft Inflammatory Factor-1 Expression Correlates With Cardiac Rejection and Development of Cardiac Allograft Vasculopathy
Autieri et al.
Circulation 2002;106:2218-2223.
ABSTRACT | FULL TEXT  

Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation
Hunt and Tyagi
Am. J. Physiol. Cell Physiol. 2002;283:C1073-C1079.
ABSTRACT | FULL TEXT  

Increased Tissue Factor Expression Predicts Development of Cardiac Allograft Vasculopathy
Yen et al.
Circulation 2002;106:1379-1383.
ABSTRACT | FULL TEXT  

Inhibition of Major Histocompatibility Complex Class II Gene Transcription by Nitric Oxide and Antioxidants
Grimm et al.
J. Biol. Chem. 2002;277:26460-26467.
ABSTRACT | FULL TEXT  

Are we clear about the mechanisms by which biopsy evidence of interstitial fibrosis following cardiac transplantation helps predict late post-transplant coronary artery disease?
Herskowitz and Ansari
J Am Coll Cardiol 2002;39:978-980.
FULL TEXT  

Coronary flow reserve and nitric oxide synthases after cardiac transplantation in humans
Wildhirt et al.
Eur. J. Cardiothorac. Surg. 2001;19:840-847.
ABSTRACT | FULL TEXT  

Endothelial Dysfunction and Denudation in Rat Aortic Allografts
Andriambeloson et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:67-73.
ABSTRACT | FULL TEXT  

Value of Serum-Soluble Intercellular Adhesion Molecule-1 for the Noninvasive Risk Assessment of Transplant Coronary Artery Disease, Posttransplant Ischemic Events, and Cardiac Graft Failure
Labarrere et al.
Circulation 2000;102:1549-1555.
ABSTRACT | FULL TEXT  

Cardiac-Specific Troponin I Levels and Risk of Coronary Artery Disease and Graft Failure Following Heart Transplantation
Labarrere et al.
JAMA 2000;284:457-464.
ABSTRACT | FULL TEXT  

TRANSFORMING GROWTH FACTOR {beta} IN RELATION TO CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
Aziz et al.
J. Thorac. Cardiovasc. Surg. 2000;119:700-708.
ABSTRACT | FULL TEXT  

Endothelial Apoptosis: Could It Have a Role in the Pathogenesis and Treatment of Disease?
Stefanec
Chest 2000;117:841-854.
ABSTRACT | FULL TEXT  

Graft coronary artery disease is strongly related to the aetiology of heart failure and cellular rejections
Lindelow et al.
Eur Heart J 1999;20:1326-1334.
ABSTRACT  

Human Vascular Endothelial Cells Favor Clonal Expansion of Unusual Alloreactive CTL
Biedermann and Pober
J. Immunol. 1999;162:7022-7030.
ABSTRACT | FULL TEXT  

Long-term Exercise and Atherogenic Activity of Blood Mononuclear Cells in Persons at Risk of Developing Ischemic Heart Disease
Smith et al.
JAMA 1999;281:1722-1727.
ABSTRACT | FULL TEXT  

Low incidence of transplant coronary artery disease in chinese heart recipients
Hsu et al.
J Am Coll Cardiol 1999;33:1573-1577.
ABSTRACT | FULL TEXT  

Endothelial Activation and Posttransplant CAD
Journal Watch Cardiology 1997;1997:7-7.
FULL TEXT  

Endomyocardial Biopsies: An Early Warning System for Chronic Transplant Arteriopathy
Aretz and Colvin
JAMA 1997;278:1197-1198.
ABSTRACT